Clinical features of bronchial asthma persistence in children with alternative content of respiratory tract remodeling markers
DOI:
https://doi.org/10.15574/SP.2022.128.25Keywords:
bronchial asthma, children, bronchial remodelingAbstract
The research of bronchial remodeling and the role of angiogenesis processes in it are currently relevant for the study of the phenotypic features of the course of bronchial asthma in children and require further study in order to develop preventive and therapeutic measures.
Purpose - to optimize treatment and prevention measures for persistent bronchial asthma (pBA) in children, to determine the clinical and anamnestic features of its phenotype, taking into account the accumulation of mediators of neoangiogenesis (фактора росту ендотелію судин - VEGF, матрична металопротеїназа-9 - MMP-9) in the respiratory tract as markers of bronchial remodeling.
Materials and methods. A comprehensive examination of 116 children with pBA aged from 6 to 17 years (average age 11.6±0.29 years) and disease duration of 4.9±0.38 years was conducted. Three clinical groups were formed: the Group 1 was formed by 37 children with pBA with VEGF >80.0 ng/ml and MMP-9 >5.2 ng/ml in the sputum supernatant; the Group 2 included 41 children with an excess of one of these markers; and the control group consisted of 38 patients with values of these biomarkers below the median (VEGF<80.0 ng/ml and MMP-9 <5.2 ng/ml). The main clinical characteristics of the observation groups were comparable.
Results. The article shows that uncontrolled pBA (sum of points >20) during the 4-year follow-up occurred most often in children of еру Group 1 and the Group 2, and indications of insufficient control of asthma indicated a probable risk of developing structural changes in the bronchi: OR - 2.23 (95% CI: 1.2-4.1), RR - 1.5 (95% CI: 1.0-2.2) and RR - 22%. The severe course of pBA was also associated with the risk of bronchial remodeling with the accumulation of angiogenesis mediators in their lumen as follows: OR - 2.2 (95% CI: 1.1-4.52), RR - 1.42 (95% CI: 1.0-2.5) and AR - 19%.
Accumulation of remodeling markers in airways in patients with asthma in the Group 1 and the Group 2 is associated with a predominantly eosinophilic phenotype of the disease. At the same time, patients with a low content of markers of bronchial remodeling in sputum (control group) have better chances of achieving complete control over the symptoms of pBA compared to children with a high content (total absolute risk - 19.0%, total relative risk - 45.1%, the minimum number of patients who need to be treated to obtain a positive result - 2.2) and average (total absolute risk - 10.2%, total relative risk - 30.6%, the minimum number of patients who need to be treated to obtain a positive result - 3.2) content of angiogenesis factors in sputum.
Conclusions. In patients with pBA, the accumulation of markers of bronchial remodeling in the lumen of the airways was associated with a severe uncontrolled course of asthma and worse chances of achieving disease control.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Abramson MJ, Guo Y. (2019). Indoor Endotoxin Exposure and Ambient Air Pollutants Interact on Asthma Outcomes. Am. J. Respir. Crit. Care Med. 200: 652-654. https://doi.org/10.1164/rccm.201904-0842ED; PMid:31063402 PMCid:PMC6775880
Aoshiba K, Nagai A. (2004). Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Clin. Rev. Allergy Immunol. 27: 35-43. https://doi.org/10.1385/CRIAI:27:1:035; PMid:15347849
Boulet LP, Boulet V, Milot J. (2002). Нow should we quantify asthma control?: a proposal. Chest. 122: 2217-2223. https://doi.org/10.1378/chest.122.6.2217; PMid:12475866
Bullone M, Lavoie JP. (2020). The equine asthma model of airway remodeling: from a veterinary to a human perspective. Cell Tissue Res. 380 (2): 223-236. https://doi.org/10.1007/s00441-019-03117-4; PMid:31713728
Camoretti-Mercado B, Lockey RF. (2021). Airway smooth muscle pathophysiology in asthma. J Allergy Clin Immunol. 147 (6): 1983-1995. https://doi.org/10.1016/j.jaci.2021.03.035; PMid:34092351
Fang L, Sun Q, Roth M. (2020). Immunologic and Non-Immunologic Mechanisms Leading to Airway Remodeling in Asthma. Int J Mol Sci. 23; 21 (3): 757-762. https://doi.org/10.3390/ijms21030757; PMid:31979396 PMCid:PMC7037330
Fouka E, Domvri K, Gkakou F, Alevizaki M, Steiropoulos P, Papakosta D, Porpodis K. (2022). Recent insights in the role of biomarkers in severe asthma management. Front Med (Lausanne). 26 (9): 992565. https://doi.org/10.3389/fmed.2022.992565; PMid:36226150 PMCid:PMC9548530
Guida G, Bagnasco D, Carriero V, Bertolini F, Ricciardolo FLM, Nicola S, Brussino L, Nappi E, Paoletti G, Canonica GW, Heffler E. (2022). Critical evaluation of asthma biomarkers in clinical practice. Front Med (Lausanne). 10 (9): 969243. https://doi.org/10.3389/fmed.2022.969243; PMid:36300189 PMCid:PMC9588982
Huang Y, Qiu C. (2022). Research advances in airway remodeling in asthma: a narrative review. Ann Transl Med. 10 (18): 1023. https://doi.org/10.21037/atm-22-2835; PMid:36267708 PMCid:PMC9577744
Janulaityte I, Januskevicius A, Kalinauskaite-Zukauske V, Palacionyte J, Malakauskas K. (2021). Asthmatic Eosinophils Promote Contractility and Migration of Airway Smooth Muscle Cells and Pulmonary Fibroblasts in Vitro. Cells. 4; 10 (6): 1389. https://doi.org/10.3390/cells10061389; PMid:34199925 PMCid:PMC8229663
Kaur R, Chupp G. (2019). Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol. 144 (1): 1-12. https://doi.org/10.1016/j.jaci.2019.05.031; PMid:31277742
Kim SH, Pei QM, Jiang P. (2019). Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma. Respir Res. 20: 282. https://doi.org/10.1186/s12931-019-1245-1; PMid:31831011 PMCid:PMC6909599
Li Z, Yuan X, Wang B. (2020). Icariin alleviates transforming growth factor-β1-induced epithelial-mesenchymal transition by targeting Smad and MAPK signaling pathways. Am J Transl Res. 12: 343-360.
Pałgan K, Bartuzi Z. (2015). Angiogenesis in bronchial asthma. Int J Immunopathol Pharmacol. 28: 415-420. https://doi.org/10.1177/0394632015580907; PMid:25875602
Pan YL, Zhu YT, Li MX. (2014). Research progress of airway remodeling in bronchial asthma. Int. J. Respir. 23: 26-27.
Papakonstantinou E, Koletsa T, Zhou L, Fang L, Roth M, Karakioulaki M, Savic S, Grize L, Tamm M, Stolz D. (2021). Bronchial thermoplasty in asthma: an exploratory histopathological evaluation in distinct asthma endotypes/phenotypes. Respir Res. 28; 22 (1): 186-192. https://doi.org/10.1186/s12931-021-01774-0; PMid:34183014 PMCid:PMC8240300
Porpodis K, Tsiouprou I, Apostolopoulos A, Ntontsi P, Fouka E, Papakosta D, Vliagoftis H, Domvri K. (2022). Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice. J Pers Med. 30; 12 (7): 1093. https://doi.org/10.3390/jpm12071093; PMid:35887589 PMCid:PMC9316404
Shifren A, Witt C, Chandrika C, Castro M. (2012). Mechanisms of Remodeling in Asthmatic Airways. Journal of allergy. 31: 604-609. https://doi.org/10.1155/2012/316049; PMid:22315625 PMCid:PMC3270414
Tiotiu A. (2021). Applying personalized medicine to adult severe asthma. Allergy Asthma Proc. 1; 42 (1): 8-16. https://doi.org/10.2500/aap.2021.42.200100; PMid:33404396
Wang X, Khalil RA. (2018). Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Adv Pharmacol. 81: 241-330. https://doi.org/10.1016/bs.apha.2017.08.002; PMid:29310800 PMCid:PMC5765875
Zhang J, Dong L. (2020). Status and prospects: personalized treatment and biomarker for airway remodeling in asthma. Thorac Dis. 12 (10): 6090-6101. https://doi.org/10.21037/jtd-20-1024; PMid:33209441 PMCid:PMC7656354
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.